C. Álvarez-Reguera

OP0152 COMPARISON OF DIAGNOSTIC CRITERIA IN BEHÇET DISEASE AND SENSITIVITY IN DIAGNOSING SEVERE MANIFESTATIONS.

R. Blanco, M. González‐Gay, L. Sánchez-Bilbao, 2021 .

Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review

R. Blanco, M. González‐Gay, I. Ferraz-Amaro, 2022, Frontiers in Medicine.

Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review

R. Blanco, M. González‐Gay, V. Calvo-Río, 2022, Therapeutic advances in musculoskeletal disease.

Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study

M. González-Gay, J. Callejas-Rubio, N. Ortego-Centeno, 2020, Journal of clinical medicine.

Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review

D. San Segundo, M. Gutiérrez-Larrañaga, R. Blanco, 2022, Therapeutic advances in musculoskeletal disease.

POS1231 COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATED INFLAMMATORY DISEASES. EPIDEMIOLOGICAL STUDY IN A SINGLE UNIVERSITY HOSPITAL

R. Blanco, M. González‐Gay, D. Prieto-Peña, 2021, Annals of the Rheumatic Diseases.

Single-center study on features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors.

A. Batlle-López, D. Prieto-Peña, L. Sánchez-Bilbao, 2023, European journal of internal medicine.